- Home
- IMVT vs ALRM Comparison
IMVT vs ALRM Comparison
Compare IMVT & ALRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMVT
- ALRM
- Stock Information
- Founded
- IMVT 2018
- ALRM 2000
- Country
- IMVT United States
- ALRM United States
- Employees
- IMVT N/A
- ALRM N/A
- Industry
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- ALRM Computer Software: Prepackaged Software
- Sector
- IMVT Health Care
- ALRM Technology
- Exchange
- IMVT Nasdaq
- ALRM Nasdaq
- Market Cap
- IMVT 2.7B
- ALRM 2.8B
- IPO Year
- IMVT N/A
- ALRM 2015
- Fundamental
- Price
- IMVT $16.08
- ALRM $54.63
- Analyst Decision
- IMVT Buy
- ALRM Buy
- Analyst Count
- IMVT 11
- ALRM 6
- Target Price
- IMVT $37.38
- ALRM $64.33
- AVG Volume (30 Days)
- IMVT 1.3M
- ALRM 261.3K
- Earning Date
- IMVT 08-08-2025
- ALRM 08-07-2025
- Dividend Yield
- IMVT N/A
- ALRM N/A
- EPS Growth
- IMVT N/A
- ALRM 39.57
- EPS
- IMVT N/A
- ALRM 2.36
- Revenue
- IMVT N/A
- ALRM $955,366,000.00
- Revenue This Year
- IMVT N/A
- ALRM $6.93
- Revenue Next Year
- IMVT N/A
- ALRM $4.28
- P/E Ratio
- IMVT N/A
- ALRM $23.68
- Revenue Growth
- IMVT N/A
- ALRM 6.71
- 52 Week Low
- IMVT $12.72
- ALRM $48.23
- 52 Week High
- IMVT $34.47
- ALRM $71.98
- Technical
- Relative Strength Index (RSI)
- IMVT 41.15
- ALRM 41.03
- Support Level
- IMVT $15.31
- ALRM $54.89
- Resistance Level
- IMVT $17.12
- ALRM $56.70
- Average True Range (ATR)
- IMVT 0.84
- ALRM 0.95
- MACD
- IMVT -0.27
- ALRM 0.03
- Stochastic Oscillator
- IMVT 20.53
- ALRM 25.27
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.
About ALRM Alarm.com Holdings Inc.
Alarm.com Holdings Inc has a cloud-based platform that offers an expansive suite of IoT solutions addressing world-wide opportunities in the residential, multi-family, small business and enterprise commercial markets. It has two reportable segments: Alarm.com & Other. The Alarm.com segment represents the cloud-based Software platforms for intelligently connected property & related solutions. The other segment is focused on researching, developing & offering residential & commercial automation solutions & energy management products & services in adjacent markets. The majority of revenue is from the Alarm.com segment. The platform allows home & business owners to secure their properties and automate & control an array of connected devices.